Egle Therapeutics
Modulating T-regulatory cells to balance immunity
France
45 employees
Grant
Total: $49.30M
Biotechnology, Health Care +1
General Information
France
BounceWatch is an independent company data service, not affiliated with Egle Therapeutics. To contact Egle Therapeutics, visit egle-tx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Egle Therapeutics compare?
A PDF of Egle Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Egle Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Egle Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
France Market
Biotechnology
About Egle Therapeutics
Business keywords: immunomodulation, T-regulatory cells, immunotherapy, oncology, autoimmune diseases, immune suppressor, regulatory T-cells, Paris, emerging, cancer treatment, immune system, therapeutic development
Services & Products
Target Customers
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €9.30M | 1 |
France 2030
|
17 Mar 2025 |
| Series A | €40.00M | 6 |
|
22 Oct 2021 |
Egle Therapeutics Alternatives & Competitors
View All Alternatives
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the tre...
FAQ About Egle Therapeutics
Source: BounceWatch company record for Egle Therapeutics, https://bouncewatch.com/company/egle-therapeutics, updated 11 June 2025. When citing, please name BounceWatch and link this page.
